SCHEMBL7288173

SCHEMBL7288173

O=c1cc2c(nn1-c1ccc(Cl)cc1)-c1cc(F)ccc1SCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VHL P40337 1/20 0.40
ELOC Q15369 1/20 0.40
ELOB Q15370 1/20 0.40
MMP12 P39900 1/20 0.38
ALDH1A1 P00352 4/20 0.37
LMNA P02545 4/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
KMT2A Q03164 6/20 0.36
GAA P10253 4/20 0.36
MEN1 O00255 5/20 0.36
MAPT P10636 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CTSL P07711 1/20 0.35
NPY1R P25929 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7288920 0.93 KMT2A (0.39) VHLELOCELOBALDH1A1LMNA
SCHEMBL7286458 0.91 VHL (0.50) VHLELOCELOBMMP12ALDH1A1
SCHEMBL7289639 0.89 IDO1 (0.36) VHLELOCELOBALDH1A1LMNA
SCHEMBL7286338 0.87 VHL (0.40) VHLELOCELOBMMP12ALDH1A1
SCHEMBL7286267 0.85 ALDH1A1 (0.46) VHLELOCELOBALDH1A1LMNA
SCHEMBL9411167 0.84 MAPT (0.41) VHLELOCELOBMMP12ALDH1A1
SCHEMBL9193135 0.84 RYR2 (0.41) VHLELOCELOBMMP12ALDH1A1
SCHEMBL9192544 0.84 CA12 (0.44) VHLELOCELOBMMP12ALDH1A1
SCHEMBL10365902 0.84 ALDH1A1 (0.46) ALDH1A1LMNAHPGDALOX12KMT2A
SCHEMBL9411122 0.83 MAPT (0.38) VHLELOCELOBMMP12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0487768-B1 Pharmaceutical composition with improved dissolution property YOSHITOMI PHARMACEUTICAL (JP) 1995-01-25 EP claimed
EP-0487768-A1 Pharmaceutical composition with improved dissolution property YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-06-03 EP claimed
EP-0281045-B1 BENZOTHIEPINO (5,4-C) PYRIDAZINE COMPOUNDS AND THEIR PHARMACEUTICAL USES Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1991-12-27 EP claimed
US-4849421-A SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1989-07-18 US claimed
EP-0281045-A1 Benzothiepino (5,4-c) pyridazine compounds and their pharmaceutical uses Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1988-09-07 EP claimed
EP-0487768-B1 Pharmaceutical composition with improved dissolution property YOSHITOMI PHARMACEUTICAL (JP) 1995-01-25 EP disclosed
EP-0487768-A1 Pharmaceutical composition with improved dissolution property YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-06-03 EP disclosed
EP-0281045-B1 BENZOTHIEPINO (5,4-C) PYRIDAZINE COMPOUNDS AND THEIR PHARMACEUTICAL USES Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1991-12-27 EP disclosed
US-4849421-A SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1989-07-18 US disclosed
EP-0281045-A1 Benzothiepino (5,4-c) pyridazine compounds and their pharmaceutical uses Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1988-09-07 EP disclosed